160 related articles for article (PubMed ID: 12593038)
1. [Iron protein-succinylate in the treatment of adult iron-deficiency anemia].
Pujol Farriols R; Anglada Oriol M; Formiga Pérez F; Fernández-Sabe N; Mitjavila Vileró F; Vidaller Palacín A
An Med Interna; 2002 Dec; 19(12):651-2. PubMed ID: 12593038
[No Abstract] [Full Text] [Related]
2. Comparative study of tolerability and efficacy of iron protein succinylate versus iron hydroxide polymaltose complex in the treatment of iron deficiency in children.
Haliotis FA; Papanastasiou DA
Int J Clin Pharmacol Ther; 1998 Jun; 36(6):320-5. PubMed ID: 9660039
[TBL] [Abstract][Full Text] [Related]
3. [Legofer--a new approach in the treatment of iron deficiency. Pharmacological and biopharmacological characteristics of legofer (ferric protein succinylate)].
Akush Ginekol (Sofiia); 2002; 41 Suppl 1():21-3. PubMed ID: 12412350
[No Abstract] [Full Text] [Related]
4. Iron hydroxide polymaltose: iatrogenic cause of persistent iron deficiency anaemia despite continuous oral iron therapy.
Mehta BC
J Assoc Physicians India; 2002 Feb; 50():279-80. PubMed ID: 12038667
[No Abstract] [Full Text] [Related]
5. Iron protein succynilate in the treatment of iron deficiency: potential interaction with H2-receptor antagonists.
Bianchi FM; Cavassini GB; Leo P
Int J Clin Pharmacol Ther Toxicol; 1993 May; 31(5):209-17. PubMed ID: 8100220
[TBL] [Abstract][Full Text] [Related]
6. Oral iron.
Nurs Times; 2006 Jun 27-Jul 3; 102(26):40. PubMed ID: 16845816
[No Abstract] [Full Text] [Related]
7. Ineffectiveness of iron polymaltose in treatment of iron deficiency anemia.
Mehta BC
J Assoc Physicians India; 2003 Apr; 51():419-21. PubMed ID: 12723665
[No Abstract] [Full Text] [Related]
8. [The efficacy and tolerability of ferroproteinsuccinylate in iron deficiency].
Scremin S; Caprioglio L
Boll Chim Farm; 1988 Mar; 127(3):44S-49S. PubMed ID: 3240355
[No Abstract] [Full Text] [Related]
9. [The activity and tolerability of ferroproteinsuccinylate in the treatment of iron deficiency in surgery].
Ambrosini A
Boll Chim Farm; 1988 Mar; 127(3):40S-43S. PubMed ID: 3071379
[No Abstract] [Full Text] [Related]
10. Meta-analysis of efficacy and tolerability data on iron proteinsuccinylate in patients with iron deficiency anemia of different severity.
Köpcke W; Sauerland MC
Arzneimittelforschung; 1995 Nov; 45(11):1211-6. PubMed ID: 8929242
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerability of oral iron protein succinylate: a systematic review of three decades of research.
Martínez Francés A; Leal Martínez-Bujanda J
Curr Med Res Opin; 2020 Apr; 36(4):613-623. PubMed ID: 31944128
[No Abstract] [Full Text] [Related]
12. Ferumoxytol: an intravenous iron, riskier than iron sucrose.
Prescrire Int; 2013 Sep; 22(141):206. PubMed ID: 24171212
[No Abstract] [Full Text] [Related]
13. [Newly diagnosed iron deficiency anemia in a premenopausal woman].
Todd T; Caroe T
Praxis (Bern 1994); 2008 Jun; 97(13):735-6. PubMed ID: 18770926
[No Abstract] [Full Text] [Related]
14. Iron supplementation and erythropoiesis-stimulatory agents in the treatment of cancer anemia.
Pedrazzoli P; Rosti G; Secondino S; Siena S
Cancer; 2009 Mar; 115(6):1169-73. PubMed ID: 19152436
[TBL] [Abstract][Full Text] [Related]
15. Intravenous iron sucrose--an effective and attractive modality for perioperative anaemia management.
Froessler B; Papendorf D
Anaesth Intensive Care; 2010 Sep; 38(5):960-2. PubMed ID: 20865896
[No Abstract] [Full Text] [Related]
16. Triferic for iron replacement.
Med Lett Drugs Ther; 2017 Mar; 59(1517):55-56. PubMed ID: 28323812
[No Abstract] [Full Text] [Related]
17. [Clinical study of iron protein succinylate oral solution for preventing and treating anemia of prematurity].
Xing Y; Tong XM
Zhongguo Dang Dai Er Ke Za Zhi; 2013 Dec; 15(12):1059-63. PubMed ID: 24342196
[TBL] [Abstract][Full Text] [Related]
18. Intravenous iron replacement - management in general practice.
Naim M; Hunter J
Aust Fam Physician; 2010 Nov; 39(11):839-41. PubMed ID: 21301656
[TBL] [Abstract][Full Text] [Related]
19. Clinical case reports raise doubts about the therapeutic equivalence of an iron sucrose similar preparation compared with iron sucrose originator.
Stein J; Dignass A; Chow KU
Curr Med Res Opin; 2012 Feb; 28(2):241-3. PubMed ID: 22181342
[TBL] [Abstract][Full Text] [Related]
20. A comparative study on the gastroduodenal tolerance of different antianaemic preparations.
Idoate Gastearena MA; Gil AG; Azqueta A; Coronel MP; Gimeno M
Hum Exp Toxicol; 2003 Mar; 22(3):137-41. PubMed ID: 12723894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
